Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
- Authors
- Anshul Kumar
- Bala,Krishnan,K
- Baohua,Y.
- T.M. Bauer
- J.C. Bendell
- Bower,M. .
- C.D. Britten
- J.R. Brown
- N.L. Busaidy
- J.C. Byrd
- Cantley,L.C
- Chalhoub,N.
- S.E. Coutré
- M.C. Crouthamel
- Curran,E.
- Doi,T.
- Dreyling,M.
- Durgadas Anghore
- Erdmann,T.
- I.W. Flinn
- A.K. Gopal
- R.A. Graham
- R.S. Guilherme
- S.E. Herman
- S.M. Horwitz
- Iyengar,S.
- B.S. Kahl
- B.S. Kahl
- Klumb,C.E
- Z.A. Knight
- Liu,N.
- Marincevic,M.
- Patnaik,A.
- Paul,J.
- Pongas,G.
- Pooja Chawla
- Quaschning,T.
- Ravindra K. Rawal
- S.J. Roffey
- Rohit Bhatia
- Sarker,D.
- W.J. Scott
- G.I. Shapiro
- Shimada,M.
- J.D. Symons
- Taylor,E. .J
- U. .S
- Vanhaesebroeck,B.
- Vipin Saini
- M.L. Wang
- A.S. Weidner
- W.H. Wilson
- T.A. Yap
- A.D. Zelenetz
- Publication date
- Publisher
- 'Bentham Science Publishers Ltd.'
- Doi
Abstract
Abstract is not available.Similar works
Available Versions
Last time updated on 05/09/2020